ArticleInternational journal of women's health2026
Pancreatitis in Women of Reproductive Age: Global Burden, Rising Incidence in Youth, and Forecasts to 2050.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Given the limited epidemiological evidence specifically focusing on women of reproductive age, this study aimed to systematically assess the global disease burden trends of pancreatitis among women aged 15-49 from 1990 to 2021 and forecasts its projected burden from 2022 to 2050. Methods: Using open data from the Global Burden of Disease (GBD) database, we calculated temporal trends in the disease burden using the Joinpoint regression model and age-period-cohort (APC) analysis, and projected the disease burden of pancreatitis from 2022 to 2050 using the Bayesian Age-Period-Cohort Model (BAPC). Results: From 1990 to 2021, the global age-standardized incidence rate (ASIR) and disability-adjusted life years (DALY) rate showed overall downward trends [estimated annual percentage change (EAPC) = -0.37 and -0.80, respectively]. Conversely, ASIR exhibited upward trends in low-middle and low socio-demographic index (SDI) regions (EAPC = 0.30 and 0.12), and notably among young women under 25 (EAPC = 0.45 for ages 15-19). Eastern Europe had the highest age-standardized DALY rate (116.37) in 2021 and was the only region with an increased burden (EAPC = 1.36). APC analysis revealed the highest local drift in ASIR for women aged 15-19 (0.31). BAPC forecasts indicate the global ASIR will continue to rise and accelerate, reaching 28.10 by 2050. Conclusion: From 1990 to 2021, the burden of acute pancreatitis declined significantly in women aged 15-49, while low and low middle SDI experienced an upward trend in ASIR, whereas younger age groups (<25) saw rising ASIR rates. Eastern Europe was the only worsening trend. APC analysis revealed 15-19 age group experienced the most localized ASIR drift. Prospective projections indicate this population will continue to accelerate by 2050.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.